Dr. Ken Macnamara is a seasoned leader in the biotech and biopharma industries, known for his success in driving innovation, commercialization, and high-value exits.

Over his career, he has played pivotal roles in scaling multiple companies most recently as Chief Product Officer at AskBio (a Bayer company)

In January 2024, Dr. Macnamara co-founded Trogenix and serves as CEO, focused on developing transformative genetic medicines to address devastating diseases.